Immediate Impact

1 by Nobel laureates 3 from Science/Nature 53 standout
Sub-graph 1 of 24

Citing Papers

Translating p53-based therapies for cancer into the clinic
2024 Standout
Deciphering breast cancer: from biology to the clinic
2023 Standout
2 intermediate papers

Works of Jill Hood being referenced

CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy
2020
Phase I, Pharmacokinetic, and Pharmacodynamic Study of Intravenously Administered Ad5CMV-p53, an Adenoviral Vector Containing the Wild-Type p53 Gene, in Patients With Advanced Cancer
2006

Author Peers

Author Last Decade Papers Cites
Jill Hood 297 242 25 188 8 500
Christiane Stadler 105 79 21 340 11 522
Steven J. Strawn 219 36 13 240 12 572
Thomas G. Burdon 255 217 13 311 9 563
Kathryn Koprivnikar 334 119 18 299 9 540
Katja Althoff 166 20 21 152 6 472
Millicent Embry 224 147 9 281 11 413
Christopher Taylor 177 69 16 151 6 487
Michael G. Lemoine 276 344 30 294 7 525
Suzanne K. Chandler 333 123 16 313 8 515
P Hageman 208 85 18 181 6 446

All Works

Loading papers...

Rankless by CCL
2026